Fig. 5From: Exogenous vasopressin dose-dependently modulates gastric microcirculatory oxygenation in dogs via V1A receptorVasopressin plasma levels. Vasopressin plasma levels during baseline conditions, and 30 min after each dose escalation of vasopressin (treatment AVP) and its respective time control (treatment C). AVP: dose 1, 0.001 ng/kg/min; dose 2, 0.01 ng/kg/min; dose 3, 0.1 ng/kg/min; dose 4, 1 ng/kg/min. Data are presented as individual values + mean for n = 5 dogs; *p < 0.05 vs. baseline, #p < 0.05 vs. C, 2-way ANOVA for repeated measurements followed by Bonferroni’s post hoc testBack to article page